Evoke Pharma Inc. (EVOK) News Nov 20, 2014, 4:00

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Evoke Pharma Inc. (EVOK) News Nov 20, 2014, 4:00 p.m.
MarketWatch News on EVOK
No News currently available for EVOK

Other News on EVOK
Supernus Pharmaceuticals (SUPN) in Focus: Stock Up 9.8% - Tale of the Tape 9:32 a.m. Nov. 19, 2014 - Zacks.com
Evoke Pharma's (EVOK) CEO Dave Gonyer on Q3 2014 Results - Earnings Call Transcript 9:04 p.m. Nov. 13, 2014 - Seeking Alpha
3 Stocks Pushing The Drugs Industry Lower 3:32 p.m. Sept. 5, 2014 - TheStreet.com
3 Drugs Stocks Pushing The Industry Higher 3:32 p.m. Aug. 20, 2014 - TheStreet.com
Evoke Pharma's (EVOK) CEO Dave Gonyer on Q1 2014 Results - Earnings Call Transcript 8:13 p.m. May 13, 2014 - Seeking Alpha
10-Q: EVOKE PHARMA INC 3:14 p.m. May 13, 2014 - Edgar Online - (EDG = 10Q, 10K)
Evoke Pharma's CEO Discusses Q4 2013 Results - Earnings Call Transcript 9:16 p.m. March 25, 2014 - Seeking Alpha
10-K: EVOKE PHARMA INC 3:14 p.m. March 25, 2014 - Edgar Online - (EDG = 10Q, 10K)
Evoke Pharma Moves Full Speed Ahead 7:46 p.m. Jan. 26, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday January 23 7:30 a.m. Jan. 24, 2014 - Seeking Alpha
Evoke shares surge following positive trial results 9:34 a.m. Jan. 22, 2014 - Seeking Alpha
Evoke Pharma May Be One Of The Safest Biotech Bets Of 2014 11:00 a.m. Jan. 14, 2014 - Seeking Alpha
Aegis looks for Evoke Pharma to increase sevenfold 9:14 a.m. Nov. 19, 2013 - Seeking Alpha
10-Q: EVOKE PHARMA INC 4:44 p.m. Nov. 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Press Releases on EVOK
Dr. Kenneth J. Widder Joins Quidel's Board of Directors 4:40 p.m. Nov. 19, 2014 - Marketwired
Evoke Pharma Reports Third Quarter 2014 Results 4:06 p.m. Nov. 13, 2014 - GlobeNewswire
Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results 8:31 a.m. Nov. 6, 2014 - GlobeNewswire
Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001 7:31 a.m. Sept. 9, 2014 - GlobeNewswire
Evoke Pharma to Present at the Aegis Capital Corp. 2014 Healthcare & Technology Conference 7:37 a.m. Sept. 4, 2014 - GlobeNewswire
Evoke Pharma Reports Second Quarter 2014 Results 3:02 p.m. Aug. 13, 2014 - GlobeNewswire
Evoke Pharma Announces Initiation of a Thorough ECG (QT) Study for EVK-001 3:33 p.m. Aug. 12, 2014 - GlobeNewswire
Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2014 Financial Results 7:31 a.m. July 30, 2014 - GlobeNewswire
Evoke Pharma Secures $4.5 Million Loan Facility With Square 1 Bank 3:06 p.m. May 28, 2014 - GlobeNewswire
Evoke Pharma Reports First Quarter 2014 Results 3:06 p.m. May 13, 2014 - GlobeNewswire
Evoke Pharma Schedules Webcast and Conference Call for First Quarter 2014 Financial Results 7:31 a.m. May 6, 2014 - GlobeNewswire
Evoke Pharma Announces That EVK-001 Phase 2b Results Will be Presented at Digestive Disease Week 2014 7:31 a.m. April 28, 2014 - GlobeNewswire
Evoke Pharma Initiates Phase 3 Clinical Trial of EVK-001 for Treatment of Gastroparesis 7:31 a.m. April 22, 2014 - GlobeNewswire
Evoke Pharma Reports Fourth Quarter and Year End 2013 Results 3:30 p.m. March 25, 2014 - GlobeNewswire
Evoke Pharma Schedules Webcast and Conference Call for Fourth Quarter 2013 Financial Results 9:03 a.m. March 10, 2014 - GlobeNewswire
Evoke Pharma to Present at 26th Annual ROTH Conference 8:30 a.m. March 4, 2014 - GlobeNewswire
Evoke Pharma Study Reports Positive Results of Metoclopramide Nasal Spray for Gastroparesis in Diabetics 8:30 a.m. Jan. 22, 2014 - GlobeNewswire
Evoke Pharma to Present at Biotech Showcase(TM) 2014 8:31 a.m. Jan. 7, 2014 - GlobeNewswire
Evoke Pharma Strengthens Executive Team With Appointments of Chief Medical Officer and Senior Director of Clinical Operations 8:30 a.m. Dec. 2, 2013 - GlobeNewswire
Evoke Pharma Selects SynteractHCR as Contract Research Organization for Phase 3 Trial of EVK-001 for Gastroparesis 8:30 a.m. Nov. 26, 2013 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Deion Sanders Joins Depend: A Men's Health Push

Updated Category News Views 5

Coach Prime's New Role Just when you thought you'd heard it all in the marketing world, here comes Deion "Coach Prime" Sanders stepping up as the new face of Depend Real Fit® packaging. And why not? It's Men's Health Month—time for a wake-up call that might actually stick, if Sanders has anything to do with it. A Heavyweight Move for Proactive Health Depend® is...

Continue Reading
Inflation in Spain Experiences Slight Increase to 1.8% in October

Updated Category News Views 106

Spain's Inflation Rate Overview Spain has seen a slight increase in its European Union-harmonised 12-month inflation rate, which reached 1.8% in October, up from 1.7% in September. This information comes from preliminary data released by the National Statistics Institute (INE) on a recent Wednesday. Current Inflation Figures The latest figures align closely with the...

Continue Reading
Hyster-Yale Third Quarter Financial Performance Review

Updated Category News Views 133

Q3 2025 Consolidated Highlights Consolidated revenue reached $979 million, a 2% increase sequentially, yet a 4% decline on a year-over-year basis. Operating profit fell compared to the previous year due to elevated tariffs and reduced truck volumes. Operating cash flow improved to $37 million, reflecting enhanced inventory efficiency. Hyster-Yale, Inc. (NYSE: HY) reported...

Continue Reading
BigID Pioneers Data Labeling in Vector Databases for AI Security

Updated Category News Views 288

BigID Revolutionizes AI Data Security with New Capabilities BigID leads the charge in data security and privacy management, introducing a groundbreaking capability that enables data labeling in vector databases. This innovative step marks a significant advancement in ensuring secure AI access and sets an industry benchmark for how organizations manage sensitive data....

Continue Reading
First Horizon Corporation Plans Major Stock Redemption Announcement

Updated Category News Views 139

Stock Redemption Announcement by First Horizon Corporation First Horizon Corporation (NYSE: FHN) has made an important announcement regarding its financial strategy. The company will be redeeming all outstanding shares of its 6.625% Fixed-to-Floating Non-Cumulative Perpetual Preferred Stock, Series B, along with the associated depositary shares. This decision illustrates...

Continue Reading